A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors
Clinical trial NCT05508373 · UNKNOWN
Trial details
- NCT number
- NCT05508373
- Sponsor
- Suzhou Kebo Ruijun Biotechnology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2024-06-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.